Notably, targeted inhibition of interleukin-6 receptor (IL-6R), which is highly expressed in ALDHhigh ECSCs, leads to a marked reduction in tumor cell growth, highlighting the critical role of IL-6 signaling in CSC maintenance [252]. The gene discussed is IL6R; the disease is neoplasm.